Preparation of a Newly Developed Trivalent Pasteurella multocida, Avibacterium paragallinarum, and Ornithobacterium rhinotracheale Vaccine with an Evaluation of its Protective Efficacy in Chickens

Poultry, mainly chickens, and their white meat represent one of the main, nutritionally valuable, and affordable red meat replacer sources of protein throughout the whole world with special reference to developing countries. A long list of microbial agents especially bacterial pathogens threatens c...

Full description

Bibliographic Details
Main Authors: Sally Roshdy, Rafik Soliman, Manal Aly, Lamiaa Omar, Ahmed Sameer, Heidy Abo-Elyazeed, Hassan Aboul-Ella
Format: Article
Language:English
Published: Assiut University 2023-06-01
Series:Journal of Advanced Veterinary Research
Subjects:
Online Access:https://advetresearch.com/index.php/AVR/article/view/1320
_version_ 1797657055601885184
author Sally Roshdy
Rafik Soliman
Manal Aly
Lamiaa Omar
Ahmed Sameer
Heidy Abo-Elyazeed
Hassan Aboul-Ella
author_facet Sally Roshdy
Rafik Soliman
Manal Aly
Lamiaa Omar
Ahmed Sameer
Heidy Abo-Elyazeed
Hassan Aboul-Ella
author_sort Sally Roshdy
collection DOAJ
description Poultry, mainly chickens, and their white meat represent one of the main, nutritionally valuable, and affordable red meat replacer sources of protein throughout the whole world with special reference to developing countries. A long list of microbial agents especially bacterial pathogens threatens chickens’ production cycles.  They constitute one of the major problems facing the rapidly expanding poultry industry and are responsible for considerable economic losses. Fowl cholera, infectious coryza, and ornithobacteriosis (ORT) were among the serious bacterial infections that affect the respiratory tract of chickens with a global adverse effect on poultry production. A formalinized whole culture vaccine composed of Pasteurella multocida serotypes A5, A8, A9, and D2, Avibacterium paragallinarum serotypes A and C, and Ornithobacterium rhinotracheale serotype A was prepared. This polyvalent vaccine proved to be safe producing no adverse side effects when injected in chickens. The immunizing efficacy of this vaccine was evaluated in specific pathogen-free (SPF) chickens, which were immunized at 6 weeks of age. The protective efficacy of the vaccine was determined using a challenge test. The developed vaccine was effective in protecting chickens against fowl cholera, infectious coryza, and ornithobacteriosis in chickens against challenge with these pathogens. Vaccinated chickens challenged with virulent Pasteurella multocida serotypes A5, A8, A9, and D2 showed protection rates of 86.6%, 93.3%, 93.3%, and 93.3%, respectively, as compared with 100% mortality in the non-vaccinated control. Vaccinated chickens challenged with Avibacterium paragallinarum serotypes A and C showed 86.6% and 93.3% protection rates, respectively. Also, the protection rate against challenges with virulent Ornithobacterium rhinotracheale serotype A reached 96.6%.  
first_indexed 2024-03-11T17:38:51Z
format Article
id doaj.art-7b096e98b65142ca876bd53af7a7187d
institution Directory Open Access Journal
issn 2090-6269
2090-6277
language English
last_indexed 2024-03-11T17:38:51Z
publishDate 2023-06-01
publisher Assiut University
record_format Article
series Journal of Advanced Veterinary Research
spelling doaj.art-7b096e98b65142ca876bd53af7a7187d2023-10-18T14:13:50ZengAssiut UniversityJournal of Advanced Veterinary Research2090-62692090-62772023-06-01135Preparation of a Newly Developed Trivalent Pasteurella multocida, Avibacterium paragallinarum, and Ornithobacterium rhinotracheale Vaccine with an Evaluation of its Protective Efficacy in ChickensSally Roshdy0Rafik Soliman1Manal Aly2Lamiaa Omar3Ahmed Sameer4Heidy Abo-Elyazeed5Hassan Aboul-Ella6Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Ministry of Agriculture, Egypt. Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Egypt.Department of Poultry Disease, Faculty of Veterinary Medicine, Cairo University, Egypt.Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Ministry of Agriculture, Egypt. Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Egypt.Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Egypt.Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Egypt. Poultry, mainly chickens, and their white meat represent one of the main, nutritionally valuable, and affordable red meat replacer sources of protein throughout the whole world with special reference to developing countries. A long list of microbial agents especially bacterial pathogens threatens chickens’ production cycles.  They constitute one of the major problems facing the rapidly expanding poultry industry and are responsible for considerable economic losses. Fowl cholera, infectious coryza, and ornithobacteriosis (ORT) were among the serious bacterial infections that affect the respiratory tract of chickens with a global adverse effect on poultry production. A formalinized whole culture vaccine composed of Pasteurella multocida serotypes A5, A8, A9, and D2, Avibacterium paragallinarum serotypes A and C, and Ornithobacterium rhinotracheale serotype A was prepared. This polyvalent vaccine proved to be safe producing no adverse side effects when injected in chickens. The immunizing efficacy of this vaccine was evaluated in specific pathogen-free (SPF) chickens, which were immunized at 6 weeks of age. The protective efficacy of the vaccine was determined using a challenge test. The developed vaccine was effective in protecting chickens against fowl cholera, infectious coryza, and ornithobacteriosis in chickens against challenge with these pathogens. Vaccinated chickens challenged with virulent Pasteurella multocida serotypes A5, A8, A9, and D2 showed protection rates of 86.6%, 93.3%, 93.3%, and 93.3%, respectively, as compared with 100% mortality in the non-vaccinated control. Vaccinated chickens challenged with Avibacterium paragallinarum serotypes A and C showed 86.6% and 93.3% protection rates, respectively. Also, the protection rate against challenges with virulent Ornithobacterium rhinotracheale serotype A reached 96.6%.   https://advetresearch.com/index.php/AVR/article/view/1320Trivalent vaccinePoultry infectious diseasesBacterial respiratory pathogenseconomic white meat sourceimmunizing efficacy
spellingShingle Sally Roshdy
Rafik Soliman
Manal Aly
Lamiaa Omar
Ahmed Sameer
Heidy Abo-Elyazeed
Hassan Aboul-Ella
Preparation of a Newly Developed Trivalent Pasteurella multocida, Avibacterium paragallinarum, and Ornithobacterium rhinotracheale Vaccine with an Evaluation of its Protective Efficacy in Chickens
Journal of Advanced Veterinary Research
Trivalent vaccine
Poultry infectious diseases
Bacterial respiratory pathogens
economic white meat source
immunizing efficacy
title Preparation of a Newly Developed Trivalent Pasteurella multocida, Avibacterium paragallinarum, and Ornithobacterium rhinotracheale Vaccine with an Evaluation of its Protective Efficacy in Chickens
title_full Preparation of a Newly Developed Trivalent Pasteurella multocida, Avibacterium paragallinarum, and Ornithobacterium rhinotracheale Vaccine with an Evaluation of its Protective Efficacy in Chickens
title_fullStr Preparation of a Newly Developed Trivalent Pasteurella multocida, Avibacterium paragallinarum, and Ornithobacterium rhinotracheale Vaccine with an Evaluation of its Protective Efficacy in Chickens
title_full_unstemmed Preparation of a Newly Developed Trivalent Pasteurella multocida, Avibacterium paragallinarum, and Ornithobacterium rhinotracheale Vaccine with an Evaluation of its Protective Efficacy in Chickens
title_short Preparation of a Newly Developed Trivalent Pasteurella multocida, Avibacterium paragallinarum, and Ornithobacterium rhinotracheale Vaccine with an Evaluation of its Protective Efficacy in Chickens
title_sort preparation of a newly developed trivalent pasteurella multocida avibacterium paragallinarum and ornithobacterium rhinotracheale vaccine with an evaluation of its protective efficacy in chickens
topic Trivalent vaccine
Poultry infectious diseases
Bacterial respiratory pathogens
economic white meat source
immunizing efficacy
url https://advetresearch.com/index.php/AVR/article/view/1320
work_keys_str_mv AT sallyroshdy preparationofanewlydevelopedtrivalentpasteurellamultocidaavibacteriumparagallinarumandornithobacteriumrhinotrachealevaccinewithanevaluationofitsprotectiveefficacyinchickens
AT rafiksoliman preparationofanewlydevelopedtrivalentpasteurellamultocidaavibacteriumparagallinarumandornithobacteriumrhinotrachealevaccinewithanevaluationofitsprotectiveefficacyinchickens
AT manalaly preparationofanewlydevelopedtrivalentpasteurellamultocidaavibacteriumparagallinarumandornithobacteriumrhinotrachealevaccinewithanevaluationofitsprotectiveefficacyinchickens
AT lamiaaomar preparationofanewlydevelopedtrivalentpasteurellamultocidaavibacteriumparagallinarumandornithobacteriumrhinotrachealevaccinewithanevaluationofitsprotectiveefficacyinchickens
AT ahmedsameer preparationofanewlydevelopedtrivalentpasteurellamultocidaavibacteriumparagallinarumandornithobacteriumrhinotrachealevaccinewithanevaluationofitsprotectiveefficacyinchickens
AT heidyaboelyazeed preparationofanewlydevelopedtrivalentpasteurellamultocidaavibacteriumparagallinarumandornithobacteriumrhinotrachealevaccinewithanevaluationofitsprotectiveefficacyinchickens
AT hassanaboulella preparationofanewlydevelopedtrivalentpasteurellamultocidaavibacteriumparagallinarumandornithobacteriumrhinotrachealevaccinewithanevaluationofitsprotectiveefficacyinchickens